The Department of Health in Abu Dhabi has achieved a significant milestone in its Emirati Genome Programme, collecting over 800,000 samples to date. This initiative, which focuses on advancing personalized, predictive, and preventive healthcare, aims to enhance wellness and extend longevity for future generations. Faisal Khalil Hassan Abdulla Haji, a leading figure in healthcare strategy at the Department of Health, emphasized the transformative impact of genomics and biotechnology on global healthcare during his address at Gitex Global 2025 in Dubai. He highlighted Abu Dhabi’s commitment to moving beyond traditional healthcare models by integrating genomics into everyday medical practices. Key initiatives include premarital genetic screening, newborn genetic screening, precision medicine for oncology and cardiovascular diseases, and pharmacogenetic programmes. These efforts leverage artificial intelligence and genetic data to improve diagnostic accuracy, treatment precision, and overall patient outcomes. Shahrukh Hashmi, Director of Research, noted that 85% of the local population has consented to participate in the programme, with over 100,000 expatriates also contributing. The Emirati Genome Programme positions Abu Dhabi as a global leader in life sciences and health innovation, offering insights that benefit patients worldwide.
UAE: Over 800,000 samples collected under Emirati Genome Programme; focus on longevity
